Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 2
1986 3
1987 2
1988 2
1989 1
1991 1
1993 1
1994 2
1995 3
1997 3
1998 1
1999 4
2000 2
2001 4
2002 2
2003 2
2005 2
2006 3
2007 1
2008 3
2009 7
2010 6
2011 4
2012 9
2013 9
2014 5
2015 4
2016 5
2017 11
2018 7
2019 14
2020 13
2021 21
2022 18
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30291194

174 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.
Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, Kostakoglu L, Serafini AN, Pampaloni MH, Jensen J, Armor T, Lin T, White T, Stambler N, Apfel S, DiPippo VA, Mahmood S, Wong V, Jimenez C. Pryma DA, et al. J Nucl Med. 2019 May;60(5):623-630. doi: 10.2967/jnumed.118.217463. Epub 2018 Oct 5. J Nucl Med. 2019. PMID: 30291194 Free PMC article. Clinical Trial.
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
Yoshinaga K, Oriuchi N, Wakabayashi H, Tomiyama Y, Jinguji M, Higuchi T, Kayano D, Fukuoka M, Inaki A, Toratani A, Okamoto S, Shiga T, Ito YM, Nakajo M, Nakajo M, Kinuya S; Drafting Committee for Guidelines on Internal Radiotherapy with ¹³¹I-MIBG; Japanese Society of Nuclear Medicine in Oncology and Imunology; Japanese Society of Nuclear Medicine. Yoshinaga K, et al. Endocr J. 2014;61(12):1171-80. doi: 10.1507/endocrj.EJ14-0211. Epub 2014 Sep 11. Endocr J. 2014. PMID: 25214026 Free article.
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
Inaki A, Shiga T, Tsushima Y, Jinguji M, Wakabayashi H, Kayano D, Akatani N, Yamase T, Kunita Y, Watanabe S, Hiromasa T, Mori H, Hirata K, Watanabe S, Higuchi T, Tomonaga H, Kinuya S. Inaki A, et al. Ann Nucl Med. 2022 Mar;36(3):267-278. doi: 10.1007/s12149-021-01699-0. Epub 2021 Dec 6. Ann Nucl Med. 2022. PMID: 34870794 Free PMC article. Clinical Trial.
174 results